InsiderTrades

Form 4 for IMAX IMAX CORP

Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-09 · accession 0001214659-24-020100 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-12-09 2024-12-09 IMAX WELTON MARK Pres, IMAX Theatres C - Cnv Deriv $20.85 +39.4K 150.7K +35% +$822.2K
D 2024-12-09 2024-12-09 IMAX WELTON MARK Pres, IMAX Theatres S - Sale $25.51 -39.4K 111.3K -26% -$1.01M
D 2024-12-09 2024-12-09 IMAX WELTON MARK Pres, IMAX Theatres C - Cnv Deriv $20.85 -39.4K 0 -100% -$822.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common common shares 2024-12-09 C A 39,432 $20.85 150,747 D — — (F1) Represents the conversion upon exercise of stock options into common shares.
2 Common common shares 2024-12-09 S D 39,432 $25.51 111,315 D — —
3 Derivative stock options (to buy) 2024-12-09 C D 39,432 $20.85 0 D $20.85 · — to 2025-03-07 39,432 common shares (F2) These options were issued in 2018 and are set to expire on March 7, 2025. The transaction was driven solely by the upcoming expiration of the options and the issuer's fourth quarter trading blackout period that commences on December 18, 2024. The trading blackout will end 24 hours after the issuer's earnings release in February 2025. (F4) This represents the number of stock options for this transaction only. Mr. Welton's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 49,504, 80,850 and 111,315, respectively. (F3) The stock options became exercisable in four installments: 7,886 on March 7, 2019, 9,858 on each of March 7, 2020 and March 7, 2021 and 11,830 on March 7, 2022.